ACC 24 Highlights
Dr. Chadi Alraies discusses the top impactful trials presented at the 2024 American College of Cardiology conference.Learn more about these important studies…
Dr. Chadi Alraies discusses the top impactful trials presented at the 2024 American College of Cardiology conference.Learn more about these important studies…
Cardiovascular events frequently recur after acute myocardial infarction, and low cholesterol efflux — a process mediated by apolipoprotein A1, which is the main protein in…
The Future of Diagnostic Tests: New Data & Modern Policy4:41 – Welcoming Remarks8:57 – Opening Keynote (Jeff Shuren, Director, CDRH, U.S. FDA)35:17 – Sessi…
As every year, the AcuteCVdays Campaign will run from April 29th until June 2nd. The 2024 edition will focus on “An update on device-therapy in…
May 2, 2024 — Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted…
May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary…
➡️ PATREON: https://www.patreon.com/DecodingGeopoliticsThis is a conversation with Ben Hodges, a retired three star general of the US army, the former Comman…
May 2, 2024 — Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more than 1 million echocardiograms, or cardiac…
Correspondence to: Rishi K. Wadhera, MD, MPP, MPhil, Section of Health Policy and Equity at the Richard A. and Susan F. Smith Center for Outcomes…
The study published in Neurology Clinical Practice states that people who take acid-reducing drugs may have a higher risk of migraine and other severe headache…
Developed by doctors, MedShr is the easiest & safest way for medical professionals to discover, discuss and share clinical cases and medical images. Join our…